A telehealth company partnered with a pharmacy that lacked a required license, raising doubts about the safety and efficacy ...

Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...

Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...

In 1967, a team including Jean-Paul Sartre put the US ‘on trial’ for its actions in Vietnam. Clive Webb’s Vietdamned surveys their efforts ...

GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

Not all weight loss programs are made equal—to reach a healthy, sustainable weight, personalized programs offer the best ...

Q1 2025 Earnings Call Transcript February 13, 2025 Veru Inc. beats earnings expectations. Reported EPS is $-0.06, ...

The Janus Henderson Global Life Sciences Fund returned -11.16% and the MSCI World Health Care IndexSM returned -11.40%. Click ...

Ozempic made headlines after a study came out linking this and similar medications like Wegovy to an eye condition that can ...

The telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide ...

Eligibility criteria Observational or interventional studies with self-reported activity (including return to sport) or knee-related outcomes after ACL injury ... 15 18 Therefore, this systematic ...